The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNKTN.L Regulatory News (NKTN)

  • There is currently no data for NKTN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed placing, debt conversion and US sale

27 Dec 2018 07:00

RNS Number : 4813L
Nektan PLC
27 December 2018
 

27 December 2018

NEKTAN PLC

("Nektan", the "Company" or the "Group")

 

Proposed placing, debt conversions and partial sale of US subsidiary

 

Nektan plc (AIM: NKTN), the fast-growing international gaming technology platform and services provider, announces that it has received in principle support to raise, in aggregate, £3.5m in cash comprising a minimum of £1.5m by way of a proposed equity placing and subscriptions for new ordinary shares of 1 pence each in the capital of the Company at a price of 15p per share and the sale of 57.5 per cent. of its US subsidiary, Respin, for £2.0m In addition, the Company has reached agreement to restructure a proportion of both the Series A convertible loan notes and of the loan from Gary Shaw, Executive Director of the Company. 

 

Proposed placing

 

The Company announces that it intends to raise a minimum of £1.5 million by way of a proposed placing of new ordinary shares of 1 pence each in the capital of the Company ("New Ordinary Shares") to institutional and other investors at a price of 15 pence per share (the "Placing Price") (the "Proposed Placing"). To date, the Company has secured conditional subscription agreements from Gary Shaw, Executive Director of the Company, certain members of staff and certain shareholders of the Company for, in aggregate, £1.1 million as well as indications of interest for the remaining £0.4 million. Authority to allot the new shares will be sought at the Company's Annual General Meeting ("AGM"), currently scheduled for 7 February 2019.

 

Debt conversion - convertible loan notes

The Company also announces that it has agreed with loan noteholders representing a majority of the Series A convertible loan notes to amend the terms of the Series A convertible loan notes so that convertible loan noteholders can convert both their underlying principal and their accrued interest at the Placing Price for a period up to the AGM following which the terms of the convertible loan notes will be amended such that the conversion price reverts to 2 times the most recent equity issue price, but can be no lower than 30 pence and no higher than 209 pence, and the coupon reduces from 10 per cent. per annum to 2.5 per cent. per annum.

 

To date, the Company has reached agreement with certain Series A convertible loan noteholders for the conversion of, in aggregate, approximately £4.3 million of the outstanding balance of the £8.1m principal and £1.2 million of accrued interest which will result in the issue of a total of approximately 36.6 million new ordinary shares. On the basis that no further principal or accrued interest is converted by the AGM, this would leave a total of £3.8 million of the Series A convertible loan notes outstanding, £1.1 million of the Series B convertible loan notes outstanding and £0.8m of the accrued interest outstanding.

 

Debt conversion - shareholder loan

 

The Company has also agreed with Gary Shaw to convert £650,000 of his outstanding loan and the accrued interest of £148,252 into New Ordinary Shares at the Placing Price which will result in the issue of, in aggregate, 5,321,680 New Ordinary Shares. Following conversion, this will leave a balance outstanding on the loan of £535,000. Gary Shaw and Sandeep Reddy have also both agreed to defer the redemption date of their respective loans to no earlier than 31 March 2020. This is subject to the Company's nominated adviser, Stockdale Securities Limited, confirming that the amended terms of the shareholder loans are fair and reasonable insofar as the Company's shareholders are concerned.

 

Proposed sale of majority shareholding of Respin

 

The Company announces that it is in advanced discussions to sell 57.5 per cent. of the issued share capital of its US subsidiary, Respin, to a third party for total consideration of £2.0 million in cash as well as the provision of £300,000 in working capital to Respin by the investing entity. Of the total consideration payable, £1.0 million would be paid on completion, expected to be early in 2019, and a further £1.0 million during 2019.

 

Conditionality

 

Each of the Proposed Placing, debt conversions and sale of a majority stake in Respin are inter-conditional. In addition, as announced in its audited final results for the year ended 30 June 2018 released separately today, the Company has entered into negotiations with HMRC in order to agree a payment schedule for £2.9m of owed UK point of consumption tax. As a result, each of the above are conditional on the successful conclusion of those negotiations.

The Company intends in due course to publish a circular containing details of the Proposed Placing, the debt conversions, sale of a majority stake in Respin and a notice convening a general meeting to approve the issue of the New Ordinary Shares (the "Circular"). Further announcements will be made as appropriate. Further information and details of the sale of a majority stake in Respin will be included in subsequent announcements and the Circular in compliance with Rule 12 and Schedule Four of the AIM Rules for Companies.

 

Lucy Buckley, Chief Executive Officer of Nektan, said:

 

"We are very pleased to have received significant support from both existing shareholders and new investors as well as a material proportion of our CLN holders. In addition, finding an investor for our US subsidiary, Respin, is a significant milestone in Nektan's history."

 

 

For further information on the Group, please contact:

Nektan

Lucy Buckley, Chief Executive Officer

Patrick Sinclair, Chief Financial Officer

+44 20 3463 8735

 

Stockdale Securities Limited (Nominated Advisor and Joint Broker)

Tom Griffiths / Ed Thomas

+44 20 7601 6100

Smaller Company Capital Limited (Joint Broker)

Rupert Williams / Jeremy Woodgate

+44 20 3651 2911

Nominis Advisory (PR Adviser)

Angus Campbell

+44 7 881 625 098

Email: angus@nominis.co

 

 

Further information on Nektan can be found on the Group's website at www.nektan.com.

 

About Nektan:

Nektan is an international B2B and white label gaming software and services provider, operating in the regulated, interactive real money gaming (RMG) space, delivering original and innovative solutions to commercial organisations that have established online audiences.

 

Nektan's full end-to-end technology platform, Evolve, simplifies and supports the route to mobile and desktop gaming revenues, managing the full customer experience and back-office operations, allowing commercial partners to focus on marketing the product to their consumers.

 

Nektan's US operating subsidiary, provides US land-based casinos with in-venue mobile gaming solutions which allow operators to add mobile technology and content to their existing offerings, with products accessible to players across both cabinets and mobile devices inside the casinos. Respin has a strong intellectual property portfolio including game patents for Rapid Games™ (on-property mobile entertainment), and other captivating concepts and brands.

 

Nektan is headquartered in Gibraltar, regulated by the Gibraltar Licensing Authority and the UK Gambling Commission, as well as in the Irish market and maintains sales and customer support operations in Europe and North America. The proprietary Evolve technology is developed and maintained by a talented and experienced team of employees from Nektan's Indian office.

 

Nektan plc was admitted to the AIM market of the London Stock Exchange in November 2014.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCDZLFLVLFLFBX
Date   Source Headline
15th May 20205:39 pmRNSNektan
15th Apr 20209:54 amRNSAppointment of Administrators & Nomad Resignation
14th Apr 20207:30 amRNSSuspension to Trading on AIM
14th Apr 20207:30 amRNSSuspension - Nektan plc
31st Jan 20209:50 amRNSIssue of Equity and Total Voting Rights
27th Jan 20207:30 amRNSRestoration - Nektan Plc
27th Jan 20207:01 amRNSTrading Update
27th Jan 20207:00 amRNSFinal Results and Restoration of Trading on AIM
9th Jan 20206:17 pmRNSHolding(s) in Company
9th Jan 20209:57 amRNSUpdate regarding publication of annual accounts
7th Jan 20205:03 pmRNSSale of the UK B2C business by the Administrators
7th Jan 20203:57 pmRNSUpdate on Restructuring
2nd Jan 20207:30 amRNSSuspension - Nektan Plc
2nd Jan 20207:00 amRNSTemporary Suspension
23rd Dec 20195:21 pmRNSDelay in publication of accounts and update
19th Dec 201912:05 pmRNSDirectorate Change
13th Dec 20194:40 pmRNSSecond Price Monitoring Extn
13th Dec 20194:35 pmRNSPrice Monitoring Extension
19th Nov 20192:15 pmRNSHolding(s) in Company
18th Nov 201912:36 pmRNSResult of Meeting, TVR & Directors' Shareholdings
5th Nov 20194:26 pmRNSFurther Issue of Equity
31st Oct 20197:00 amRNSAppointment of Joint Broker
25th Oct 20195:30 pmRNSResult of Placing and Update on Transactions
18th Oct 20195:10 pmRNSPlacing Update
9th Oct 20194:29 pmRNSPlacing Update
2nd Oct 20195:30 pmRNSPlacing Update
25th Sep 20195:44 pmRNSPlacing Update
18th Sep 20197:00 amRNSBusiness Update, Capital Restructuring and Placing
13th Aug 20194:41 pmRNSDirectorate Change
31st Jul 20197:00 amRNSQ4 Trading Update
23rd Jul 20197:00 amRNSNektan Expands into Africa
28th Jun 201911:24 amRNSChange of Adviser
27th Jun 20197:00 amRNSLaunch of New Bingo Product
24th Jun 20197:00 amRNSTrading Update
12th Jun 20193:51 pmRNSHolding(s) in Company
3rd Jun 20197:00 amRNSSenior Management Appointment
28th May 20197:00 amRNSExclusive Casino Content for BetVictor
26th Apr 20194:18 pmRNSUpdate re Inter-Conditional Transactions:Amendment
26th Apr 20193:39 pmRNSUpdate re Inter-Conditional Transactions
18th Apr 201911:04 amRNSResult of Placing
17th Apr 20197:00 amRNSSale of US Division, Equity Raise and CLN Update
5th Apr 20197:00 amRNSQ3 Trading Update
25th Mar 20197:00 amRNSInterim Results for the 6 months ended 31 Dec 2018
11th Mar 20197:00 amRNSMoPlay deal
8th Feb 20193:01 pmRNSCompany Update
8th Feb 20197:00 amRNSResult of AGM
14th Jan 20199:15 amRNSPosting of Circular and Notice of AGM
8th Jan 201912:15 pmRNSIssue of Equity
7th Jan 20197:00 amRNSQ2 Trading Update
28th Dec 20187:00 amRNSPosting of Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.